JAC Advance Access published online on September 19, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl384
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine I, Division of Infectious Diseases and Chemotherapy, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria
* To whom correspondence should be addressed. Objectives: The uncommon fungal pathogen Trichoderma shows increasing medical importance particularly in immunocompromised patients. Despite systemic antifungal therapy, prognosis of Trichoderma infection is poor regardless of the type of infection and the therapy used. The aim of the present study was to evaluate the in vitro activity and synergism of double antifungal combinations including amphotericin B, voriconazole, fluconazole, chlorhexidine digluconate and Akacid plus® against 15 isolates of Trichoderma longibrachiatum and 1 isolate of Trichoderma harzianum. Methods: Individual MICs were determined by using broth microdilution method following the NCCLS M38-A guidelines with standard RPMI 1640 broth. Synergy tests were performed using the chequerboard method. Results: All clinical Trichoderma strains showed reduced susceptibility to fluconazole (MICs Conclusions: These results demonstrate no interaction between antifungals and some degree of synergism between azoles and cationic antimicrobials against Trichoderma spp.
Received April 21, 2006
Revised June 7, 2006
Accepted August 30, 2006
Brief report
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp
Christina Kratzer 1, Selma Tobudic 1, Monika Schmoll 2, Wolfgang Graninger 1, and Apostolos Georgopoulos 1 *
2 Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9, 1060 Vienna, Austria
Apostolos Georgopoulos, E-mail: apostolos.georgopoulos{at}meduniwien.ac.at
![]()
Abstract
64 mg/L) and amphotericin B (MICs = 2 mg/L), whereas lower MICs of 0.5-1 mg/L were detected for voriconazole. Akacid plus® reached the lowest MIC values in a range of 0.06-0.5 mg/L, 4- to 32-fold higher MICs were found for chlorhexidine. No antagonism was observed for any of the antifungal combinations tested. Interaction of amphotericin B and azoles was indifferent (fractional inhibitory concentration index, FICI 2-4). The combination of one azole and one cationic biocide showed different degree of synergism (FICI 0.07-2.03). Interaction of Akacid plus® and chlorhexidine resulted in synergism for each Trichoderma isolate (FICI-range 0.05-0.5).![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. Seidl, C. Seibel, C. P. Kubicek, and M. Schmoll Sexual development in the industrial workhorse Trichoderma reesei PNAS, August 18, 2009; 106(33): 13909 - 13914. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Druzhinina, M. Komon-Zelazowska, L. Kredics, L. Hatvani, Z. Antal, T. Belayneh, and C. P. Kubicek Alternative reproductive strategies of Hypocrea orientalis and genetically close but clonal Trichoderma longibrachiatum, both capable of causing invasive mycoses of humans Microbiology, November 1, 2008; 154(11): 3447 - 3459. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kratzer, S. Tobudic, K. Macfelda, W. Graninger, and A. Georgopoulos In Vivo Activity of a Novel Polymeric Guanidine in Experimental Skin Infection with Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3437 - 3439. [Abstract] [Full Text] [PDF] |
||||


